Jiangxi Fushine Pharmaceutical Co Ltd Total Liabilities

Latest as of June 2026: CN¥2.31 Billion CNY ≈ $337.39 Million USD

Jiangxi Fushine Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Jiangxi Fushine Pharmaceutical Co Ltd (300497) has total liabilities worth CN¥2.31 Billion CNY (≈ $337.39 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Jiangxi Fushine Pharmaceutical Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Jiangxi Fushine Pharmaceutical Co Ltd (2011–2025)

Total liabilities of Jiangxi Fushine Pharmaceutical Co Ltd from 2011 to 2025. This chart illustrates how Jiangxi Fushine Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Jiangxi Fushine Pharmaceutical Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.

Jiangxi Fushine Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Jiangxi Fushine Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Smartgroup Corporation Ltd AU:SIQ	Australia	AU$437.33 Million
Taiyuan Heavy Industry Co Ltd SHG:600169	China	CN¥26.57 Billion
Five Star Bancorp NASDAQ:FSBC	USA	$4.90 Billion
Da An Gene Co Ltd of Sun Yat-Sen University SHE:002030	China	CN¥1.04 Billion
Medical Properties Trust, Inc. NYSE:MPT	USA	$10.22 Billion
E2E Networks Limited NSE:E2E	India	Rs6.43 Billion
Jiangsu Gian Technology Co Ltd SHE:300709	China	CN¥1.75 Billion
MAC Copper Ltd AU:MAC	Australia	AU$870.02 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Jiangxi Fushine Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 300497 asset base.

Liquidity & Leverage Metrics

Jiangxi Fushine Pharmaceutical Co Ltd Total Liabilities Ratios Explained

Jiangxi Fushine Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.28	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.98	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.49	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jiangxi Fushine Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jiangxi Fushine Pharmaceutical Co Ltd (2011–2025)

The table below shows the annual total liabilities of Jiangxi Fushine Pharmaceutical Co Ltd from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥2.20 Billion ≈ $322.60 Million	-6.58%
2024-12-31	CN¥2.36 Billion ≈ $345.33 Million	+0.50%
2023-12-31	CN¥2.35 Billion ≈ $343.63 Million	-0.92%
2022-12-31	CN¥2.37 Billion ≈ $346.83 Million	+34.12%
2021-12-31	CN¥1.77 Billion ≈ $258.59 Million	+77.09%
2020-12-31	CN¥997.93 Million ≈ $146.03 Million	-6.59%
2019-12-31	CN¥1.07 Billion ≈ $156.33 Million	+1.76%
2018-12-31	CN¥1.05 Billion ≈ $153.62 Million	+27.60%
2017-12-31	CN¥822.70 Million ≈ $120.39 Million	+33.95%
2016-12-31	CN¥614.20 Million ≈ $89.88 Million	+48.56%
2015-12-31	CN¥413.44 Million ≈ $60.50 Million	+18.44%
2014-12-31	CN¥349.09 Million ≈ $51.08 Million	+12.05%
2013-12-31	CN¥311.55 Million ≈ $45.59 Million	+6.80%
2012-12-31	CN¥291.70 Million ≈ $42.69 Million	+25.71%
2011-12-31	CN¥232.04 Million ≈ $33.96 Million	--

About Jiangxi Fushine Pharmaceutical Co Ltd

SHE:300497 China Biotechnology

Market Cap

$1.08 Billion

CN¥7.40 Billion CNY

Market Cap Rank

#8260 Global

#1877 in China

Share Price

CN¥13.73

Change (1 day)

-2.07%

52-Week Range

CN¥13.12 - CN¥23.34

All Time High

CN¥24.76